Skip to main content

Rein Therapeutics, Inc.

RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001420565

No open-market purchases or sales by Rein Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $42.3M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Rein Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
32
+4 vs. Q2 2024
Shares held
4.61M
−258.1K (−5.3%) vs. Q2 2024
Total value
$16.3M
+$2.88M (+21.5%) vs. Q2 2024
New holders
6
5 more added
Sold out
2
8 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 32 institutions
Q1 2021: 52 institutionsQ2 2021: 47 institutionsQ3 2021: 43 institutionsQ4 2021: 43 institutionsQ1 2022: 42 institutionsQ2 2022: 37 institutionsQ3 2022: 33 institutionsQ4 2022: 19 institutionsQ1 2023: 19 institutionsQ2 2023: 17 institutionsQ3 2023: 16 institutionsQ4 2023: 20 institutionsQ1 2024: 23 institutionsQ2 2024: 29 institutionsQ3 2024: 32 institutionsQ4 2024: 31 institutionsQ1 2025: 39 institutionsQ2 2025: 36 institutionsQ3 2025: 40 institutionsQ4 2025: 48 institutionsQ1 2026: 46 institutionsQ2 2026: 59 institutions
Value heldQ3 2024: $16.3M
Q1 2021: $48.0MQ2 2021: $41.5MQ3 2021: $33.6MQ4 2021: $18.9MQ1 2022: $16.5MQ2 2022: $8.34MQ3 2022: $5.86MQ4 2022: $3.21MQ1 2023: $1.30MQ2 2023: $1.83MQ3 2023: $1.59MQ4 2023: $3.24MQ1 2024: $11.0MQ2 2024: $13.5MQ3 2024: $16.3MQ4 2024: $13.1MQ1 2025: $10.6MQ2 2025: $9.30MQ3 2025: $9.76MQ4 2025: $12.5MQ1 2026: $14.8MQ2 2026: $42.3M
Institutions holding RNTX and their total value by quarter
QuarterHoldersValue
Q2 202659$42.3M
Q1 202646$14.8M
Q4 202548$12.5M
Q3 202540$9.76M
Q2 202536$9.30M
Q1 202539$10.6M
Q4 202431$13.1M
Q3 202432$16.3M
Q2 202429$13.5M
Q1 202423$11.0M
Q4 202320$3.24M
Q3 202316$1.59M
Q2 202317$1.83M
Q1 202319$1.30M
Q4 202219$3.21M
Q3 202233$5.86M
Q2 202237$8.34M
Q1 202242$16.5M
Q4 202143$18.9M
Q3 202143$33.6M
Q2 202147$41.5M
Q1 202152$48.0M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Rein Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding RNTX in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
University of Texas/Texas Am Investment Managment Co1,403,339$4.97M0.81%−374,488−21.1%Reduced
Alyeska Investment Group, L.P.540,000$1.91M0.01%00.0%Unchanged
Nantahala Capital Management, LLC464,367$1.64M0.14%00.0%Unchanged
Vanguard Group Inc432,201$1.53M0.00%−73,952−14.6%Reduced
Cable Car Capital LLC420,000$1.49M1.60%00.0%Unchanged
Prosight Management, LP372,157$1.32M0.33%+107,157+40.4%Added
Geode Capital Management, LLC229,817$813.8K0.00%+59,370+34.8%Added
Senvest Management, LLC230,895$801.0K0.03%00.0%Unchanged
Sigma Planning Corp212,410$751.9K0.02%+86,185+68.3%Added
Gagnon Securities LLC71,761$254.0K0.05%+33,784+89.0%Added
BlackRock, Inc.51,280$181.5K0.00%+51,280New
Texas Capital Bank Wealth Management Services Inc26,171$92.6K0.01%00.0%Unchanged
Northern Trust Corp25,763$91.2K0.00%00.0%Unchanged
Blair William & Co25,602$90.6K0.00%−2,445−8.7%Reduced
Newbridge Financial Services Group, Inc.25,000$88.5K0.03%+25,000New
Renaissance Technologies LLC13,164$46.6K0.00%−11,700−47.1%Reduced
KG&L Capital Management,LLC13,000$46.0K0.01%+13,000New
State Street Corp10,404$36.8K0.00%00.0%Unchanged
Warberg Asset Management LLC10,000$35.4K0.01%−21,354−68.1%Reduced
Wells Fargo & Company9,544$33.8K0.00%+9,544New
Royal Bank of Canada8,000$28.0K0.00%−52,241−86.7%Reduced
Morgan Stanley5,550$19.6K0.00%+4,300+344.0%Added
JFS Wealth Advisors, LLC1,590$5.63K0.00%00.0%Unchanged
US Bancorp1,250$4.42K0.00%00.0%Unchanged
Sachetta, LLC1,000$3.54K0.00%+1,000New
Bank of America Corp285$1.01K0.00%−7−2.4%Reduced
Tower Research Capital LLC (TRC)243$8600.00%−3,621−93.7%Reduced
FMR LLC233$8250.00%00.0%Unchanged
Hexagon Capital Partners LLC213$7540.00%00.0%Unchanged
Game Plan Financial Advisors, LLC25$890.00%00.0%Unchanged
Acadian Asset Management LLC17$00.00%00.0%Unchanged
Avion Wealth200$00.00%+200New
Kepos Capital LP0$00.00%−106,000−100.0%Sold out
UBS Group AG0$00.00%−3,145−100.0%Sold out
BlackRock Inc.––––Not filed